I did some quick sums - we could’ve sold it as 6% Spodumene at around A$27m if we converted it at market rates (USD6500-7000).
This does not take into account the cost of converting it.
Essentially we haven’t really lost much in selling it as DSO rather than concentrate.
Ann: Inaugural DSO Tender, page-10
Add CXO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
-0.005(4.17%) |
Mkt cap ! $246.4M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 12.5¢ | 11.5¢ | $638.8K | 5.396M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 102 | 6835182 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 1661685 | 16 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| CXO (ASX) Chart |